Dídac M.
- Country
- Spain
- Department
- Servicio de Cardiologia
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- Efficacy and Safety of Nicotinamide in Type 2 Diabetes Mellitus and Hepatic Fibrosis: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 2 of 319 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in the treatment of type 2 diabetes mellitus, focusing on innovative therapeutic approaches and metabolic regulation.
- Diabetes Management
- Metabolic Control
- Nutritional Interventions
Their work explores the use of nicotinamide as a therapeutic agent in metabolic disorders.
Hepatology
The investigator has particular expertise in liver fibrosis and its relationship with metabolic conditions.
- Liver Disease Progression
- Hepatic Fibrosis Assessment
- Liver Function Studies
Their research addresses the intersection of hepatic complications and metabolic disorders.
Therapeutic Innovation
The investigator conducts research on novel therapeutic approaches in metabolic-hepatic complications.
- Clinical Efficacy Studies
- Safety Assessment
- Treatment Optimization
Their work encompasses the evaluation of new compounds for complex metabolic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.